The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -4.73 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M 3.38 — flag raised, worth a closer lookWatch
- Earnings quality 76/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Vaxart, Inc. reports it. History and quarterly detail are in the app.
- Government Contract$224.5M
- License$8.7M
- Collaboration Revenue$2.1M
- Non Cash Royalty Revenue$1.9M
Latest filings
- 8-K · Company announcement2026-05-19
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
- 8-K · Company announcement2026-04-23
- 8-K · Company announcement2026-04-21
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Vaxart, Inc., every answer cited🔒
- The Intelligence Brief — added when Vaxart, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.